伦敦 — — 本周，在达沃斯召开的世界经济论坛年会上，药品获取基金会（AMF）正在制定一套抗菌素耐药性标准，以“跟踪制药企业如何应对耐药性的增加。
LONDON – This week, at the World Economic Forum’s annual meeting in Davos, the Access to Medicine Foundation (AMF) is launching an antimicrobial resistance (AMR) benchmark to “track how pharmaceutical companies are responding to the increase in drug-resistance.”